# Heidi Overton FDA commissioner nomination > Live situation record from CLSTR: https://clstr.news/situations/heidi-overton-fda-commissioner-nomination > Updated: 2026-08-31T21:06:50.000Z. Sources: 54. Developments: 4. President Donald Trump has nominated Dr. Heidi Overton, a physician and White House domestic policy aide, to serve as the commissioner of the Food and Drug Administration (FDA). Overton would succeed Marty Makary, who resigned in May. The nomination has drawn varied reactions. Senator Bill Cassidy, chairman of the Senate health committee, expressed concerns regarding her suitability, specifically citing her support for an executive order to alter childhood vaccination schedules. Critics have also highlighted her previous work at the America First Policy Institute and her stances on reproductive rights. Conversely, pro-life organizations have expressed support. John Mize of Americans United for Life (AUL) praised her medical background and expressed optimism that she could bring objectivity to the scrutiny of mifepristone. AUL anticipates she will be a ‘pro-life FDA commissioner’ who may expose potential damages caused by the abortion drug. President Trump has since urged the Senate to prioritize Overton’s confirmation before the 2026 midterm elections, noting that HHS Secretary Robert F. Kennedy Jr. also desires a swift process. The confirmation may face political hurdles, as Senate hearings could force Republicans to address abortion rights. The Senate is not scheduled to return to Washington until September 14. The FDA is a massive regulatory agency with a budget of approximately $7 billion. Following cuts implemented by the Department of Government Efficiency (DOGE), the agency’s workforce has been reduced from 18,200 to roughly 16,000 employees. If confirmed, Overton is tasked with advancing the ‘Make America Healthy Again’ movement and reforming clinical trials. ## Claims - President Donald Trump plans to nominate White House policy aide Heidi Overton to lead the FDA. (corroborated by 4 sources) - John Mize, CEO of Americans United for Life, believes Overton could bring renewed scrutiny to the abortion drug mifepristone. (corroborated by 2 sources) - Trump described Overton as a 'ROCKSTAR' who will help ensure the U.S. remains a world leader in scientific discovery and cures. (single source) - The FDA's Center for Tobacco Products reduced the backlog of premarket tobacco product applications by approximately 70 percent in 2025. (single source) ## Timeline ### 2026-08-31: Trump urges Senate to confirm FDA nominee Heidi Overton before midterms President Trump is urging the Senate to confirm Dr. Heidi Overton as FDA Commissioner before the 2026 midterm elections. 2 sources. https://clstr.news/cluster/trump-urges-senate-to-confirm-fda-nominee-heidi-overton-before-midterms ### 2026-08-24: Heidi Overton nominated by Trump to lead the FDA President Donald Trump has nominated White House aide Dr. Heidi Overton to lead the FDA, a move expected to impact abortion drug scrutiny and tobacco product regulations. 4 sources. https://clstr.news/cluster/heidi-overton-nominated-as-fda-commissioner ### 2026-08-21: Heidi Overton nominated by President Trump to lead the FDA President Trump has nominated physician Heidi Overton to lead the FDA, focusing on medical innovation, drug pricing, and health policy reforms. 2 sources. https://clstr.news/cluster/heidi-overton-nominated-by-president-trump-to-lead-the-fda ### 2026-08-19: Heidi Overton nominated by Trump to lead FDA President Trump has nominated White House aide Dr. Heidi Overton to lead the FDA. The nomination faces Senate scrutiny over her views on vaccines and reproductive rights. 48 sources. https://clstr.news/cluster/heidi-overton-nominated-by-donald-trump-to-lead-fda --- Cite as: Heidi Overton FDA commissioner nomination. CLSTR, https://clstr.news/situations/heidi-overton-fda-commissioner-nomination